Upcoming AbbVie dividend
Change(%)
0.00%
No change
Next payment 1.55$
Next payment date May 15, 2024
Last payment 1.55$
Last payment date Feb 15, 2024
00 D 00 H 00 M 00 S
Ex-Dividend: 4/12/24
Confirmed

May 15, 2024 is the date chosen by AbbVie for the payment of dividends, which will be 1,55 dollars per share.

Remember, investors in AbbVie (ABBV): April 11, 2024 is your last chance to buy and qualify for dividends, keeping in mind that the Record Date is April 15, 2024, when your ownership is verified.

The dividend from AbbVie, 1.55 dollars, was credited on February 15, 2024, following the ex-dividend on January 12, 2024.

As almost all North American companies do, AbbVie divides the annual dividend payment into four parts, depositing it quarterly in February, May, August and November.

However, its payout is approximately 80% and the dividend yield is around 4%.

Payout Ratio AbbVie Dividends

AbbVie paid 17% of its net income in the last fiscal period as dividends.
AbbVie's earnings (54,402,998,272.00$) are sufficient to cover the dividend payment. This payment represents 17% of the total net profit of ABBV.
Dividend payout ratio
Payout Ratio

Dividend calendar of AbbVie

These are the most important events of the AbbVie calendar in 2024:

Event Day
Last trading date April 11, 2024
Ex-Dividend (Ex-Date) April 12, 2024
Record date April 15, 2024
Date of payment May 15, 2024
Data confirmed by the company AbbVie (ABBV).
Confirmed
Source
Historical annual dividend yields of AbbVie
Over the past 5 years, AbbVie has steadily increased the annual dividend amount.
Increasing Dividends
Dividend yield
Dividend yield of AbbVie vs. the sector
AbbVie's dividend yield (3.95%) is below the sector average (4.32%).
Comparison with industry average
AbbVie's dividend yield is between the top 25% (5.77%) and top 75% (2.91%) of the sector.
Evaluation with respect to competence.
Dividend yield history in AbbVie
In the last 5 years, AbbVie's annual dividend amount has not fallen more than 10%.
Dividend stability

Dividend history of AbbVie

In this table you can see the complete history:

YearEx-DividendAmountTotal
2024
01/12/2024
1.55 $
1.55 $
2023
10/12/2023
07/13/2023
04/13/2023
01/12/2023
1.48 $
1.48 $
1.48 $
1.48 $
5.92 $
2022
10/13/2022
07/14/2022
04/13/2022
01/13/2022
1.41 $
1.41 $
1.41 $
1.41 $
5.64 $
2021
10/14/2021
07/14/2021
04/14/2021
01/14/2021
1.3 $
1.3 $
1.3 $
1.3 $
5.2 $
2020
10/14/2020
07/14/2020
04/14/2020
01/14/2020
1.18 $
1.18 $
1.18 $
1.18 $
4.72 $
2019
10/11/2019
07/12/2019
04/12/2019
01/14/2019
1.07 $
1.07 $
1.07 $
1.07 $
4.28 $
2018
10/12/2018
07/12/2018
04/12/2018
01/11/2018
0.96 $
0.96 $
0.96 $
0.71 $
3.59 $
2017
10/12/2017
07/12/2017
04/11/2017
01/11/2017
0.64 $
0.64 $
0.64 $
0.64 $
2.56 $
2016
10/12/2016
07/13/2016
04/13/2016
01/13/2016
0.57 $
0.57 $
0.57 $
0.57 $
2.28 $
2015
10/13/2015
07/13/2015
04/13/2015
01/13/2015
0.51 $
0.51 $
0.51 $
0.49 $
2.02 $
2014
10/10/2014
07/11/2014
04/11/2014
01/13/2014
0.42 $
0.42 $
0.42 $
0.4 $
1.66 $
2013
10/10/2013
07/11/2013
04/11/2013
01/11/2013
0.4 $
0.4 $
0.4 $
0.4 $
1.6 $
AbbVie dividend capture strategy
Step 1: Buy AbbVie shares (ABBV) one day before ex-dividend date
Date of purchase Apr 11, 2024
Next ex-dividend date Apr 12, 2024
Step 2: Sell AbbVie shares (ABBV) when the price recovers.
Date of sale (estimated) Apr 15, 2024
Average price recovery 3 days
Average return on cost 1.10%
The dividend capture strategy is based on historical AbbVie data. Past performance is no guarantee of future results.

Information about AbbVie

Full name AbbVie Inc.
Ticker ABBV
Sector Health Care
Industry Drug Manufacturers - General
Market Capitalization 274.31B $
Description of the company

AbbVie is a company involved in the pharmaceutical industry, designing, manufacturing and marketing drugs and solutions for the treatment of a wide variety of diseases.

It was founded from the fragmentation of Abbot Laboratories in 2013, establishing its headquarters in Illinois, USA, has sales in more than 175 countries, with subsidiaries in Germany, Bermuda and The Bahamas.

Its products cover the treatment of more than 60 pathologies, including immunology, oncology, neuroscience, ophthalmology, esthetics and virology, with research and development operations in 20 countries and more than 50,000 employees distributed among its various factories.

Its operations emphasize research and personalization of therapies, tailored to the needs of each patient, investing in technologies such as precision medicine, genetics, data convergence and genomics.

Frequently asked questions about AbbVie dividends

AbbVie pays dividends on a Trimestral basis.

AbbVie is listed on the New York Stock Exchange and is part of the Nyse.

AbbVie has the Ticker or stock code ABBV.

The CEO of AbbVie in 2024 is Mr. Richard A. Gonzalez.

AbbVie has a growing dividend program. In the last 5 years, dividends have been at least equal to or higher than the previous year.

AbbVie ForumCheck the latest comments and participate in the live chat on AbbVie stocks (ABBV).
Subscribe
Notify of
guest

0 Comments
Inline Feedbacks
View all comments